Annex Insurance (AWH, Financial) stock recently experienced a sharp decline, dropping 7.47% to $0.761 per share. The trading volume stood at 16,266 shares, with a turnover rate of 0.10% and a price fluctuation of 2.62%.
Recent financial reports show Annex Insurance faced significant challenges, recording a revenue of $2.42 million but a net loss of $3.53 million. Earnings per share were reported at -$0.28, with a gross profit of $1.42 million and a negative price-to-earnings ratio of -0.58. Currently, no institutions have issued buy, hold, or sell ratings for AWH shares.
Within the life sciences sector, where AWH operates, the overall decline was 0.15%. Some related stocks experienced notable gains, including Prenetics Global Limited and Mainz Biomed N.V. Applied DNA Sciences, Inc. was particularly active, with a turnover rate of 33.51%. Other lively stocks included Ispecimen Inc. and T2 Biosystems, Inc., with turnover rates of 5.87% and 4.33%, respectively. Stocks with significant price amplitude included Applied DNA Sciences, Inc., Bioaffinity Technologies Inc., and Burning Rock Biotech.
Annex Insurance, also known as Aspira Women's Health Inc, specializes in developing and commercializing diagnostic tests for gynecological diseases. Their product lineup includes OvaSuite, a series of blood tests using proprietary algorithms combined with patient characteristics; OvaWatch, designed to assess ovarian cancer risk in women with adnexal masses; and Ova1Plus, a combination of two FDA-approved tests for women with pelvic masses planning surgery.
